购物车

搜索结果

Search Results for " flt3 inhibitor iv "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T24067 Flt3 Inhibitor IV

Flt3 Inhibitor-IV,Flt3-IN-IV

Flt3 Inhibitor IV is a potent ATP-competitive Flt3 inhibitor.
T6479 Dovitinib lactate hydrate

Dovitinib (TKI258) Lactate,多韦替尼,Dovitinib Lactate,TKI258

VEGFR; FGFR; FLT; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Dovitinib lactate hydrate (TKI258) 是一种多靶点的酪氨酸激酶抑制剂,抑制 FLT3,c-Kit,FGFR1/3,VEGFR1/2/3和 PDGFRα/β的 IC50值分别为 1,2,8/9,10/13/8,27/210 nM。
T6289 Dovitinib

TKI258,多韦替尼,CHIR-258,度维替尼

VEGFR; FGFR; FLT; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Dovitinib (CHIR-258) 是一种口服有效的、多靶点的酪氨酸激酶 (RTK) 抑制剂,具有抗肿瘤作用。
T29062 UNC3133

UNC 3133,UNC-3133

UNC3133 is a potent and selective Mer tyrosine kinase (MerTK) inhibitor with IC50 Mer 3.0 nM; Axl 17nM; Tyro 3.31 nM; FLT3 6.6 nM; PO Cmax = 0.023; IV T1/2 = 1.59 h, %F = 16. Mer tyrosine kinase (MerTK) is aberrantly elevated in various tumor cells and ha
T6193 Dovitinib Dilactic Acid

Dovitinib (TKI-258) Dilactic Acid,TKI258 Dilactic acid

VEGFR; FGFR; FLT; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Dovitinib Dilactic Acid (Dovitinib(TKI-258) Dilactic Acid) 是 Dovitinib 的双乳酸,是一种多靶点 RTK 抑制剂,主要用于 III 类 (FLT3/c-Kit),IC50 为 1 nM/2 nM,对 IV 类 (FGFR1/ 3) 和 V 类 (VEGFR1-4) RTK,IC50 为 8-13 nM,对 InsR、EGFR、c-Met、EphA2、Tie2、IGFR1 和 HER2 的效力较低。

化合物

Flt3 Inhibitor IV
Cat.No: T24067
Synonym: Flt3 Inhibitor-IV,Flt3-IN-IV
Target:
Dovitinib lactate hydrate
Cat.No: T6479
Synonym: Dovitinib (TKI258) Lactate,多韦替尼,Dovitinib Lactate,TKI258
Target: VEGFR, FGFR, FLT, PDGFR, c-Kit
Dovitinib
Cat.No: T6289
Synonym: TKI258,多韦替尼,CHIR-258,度维替尼
Target: VEGFR, FGFR, FLT, PDGFR, c-Kit
UNC3133
Cat.No: T29062
Synonym: UNC 3133,UNC-3133
Target:
Dovitinib Dilactic Acid
Cat.No: T6193
Synonym: Dovitinib (TKI-258) Dilactic Acid,TKI258 Dilactic acid
Target: VEGFR, FGFR, FLT, c-Kit
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼